- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT01994317
Use of an Algorithm to Determine IV Sedation Dosing During First-trimester Surgical Abortion
14. august 2015 opdateret af: Planned Parenthood League of Massachusetts
This study aims to compare an algorithm for IV sedation dosing to the current standard of care in patients undergoing first trimester surgical abortion.
The primary outcome is subjects' pain score with suction curettage on a 0-100 21-point scale.
Secondary outcomes include pain scores with cervical dilation and 15 minutes post-procedure, subjective pain ratings, incidents of side effects and adverse events, the frequency of additional doses of medication, recovery room time, and physician assessment of and satisfaction with pain control.
Investigators hypothesize that this algorithm will result in improved pain control, decreased frequency of additional medication doses, improved patient and physician satisfaction, without differences in side effects, adverse events or recovery room time.
Studieoversigt
Status
Afsluttet
Betingelser
Intervention / Behandling
Undersøgelsestype
Interventionel
Tilmelding (Faktiske)
196
Fase
- Ikke anvendelig
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiesteder
-
-
Massachusetts
-
Boston, Massachusetts, Forenede Stater, 02215
- Planned Parenthood
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
18 år og ældre (Voksen, Ældre voksen)
Tager imod sunde frivillige
Ingen
Køn, der er berettiget til at studere
Kvinde
Beskrivelse
Inclusion Criteria:
- Women age 18 or older seeking surgical abortion at Planned Parenthood League of Massachusetts (PPLM)
- Gestational age less than or equal to 13+6, confirmed by ultrasound
- Eligible for surgical abortion according to PPLM protocols
- Eligible for IV sedation per PPLM protocol, and desiring IV sedation for pain management
Exclusion Criteria:
- Choice of local anesthesia for pain control
- Hypersensitivity to midazolam or fentanyl
- Ineligible for IV sedation per PPLM protocol
- Need for cervical ripening with either misoprostol or mechanical priming agent (laminaria/Dilapan)
- Unable or unwilling to complete required study procedures
- Previous participation in the study
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Enkelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Aktiv komparator: Standard sedation dose
IV sedation dose calculated using current standard of care
|
IV sedation dosing calculated by standard care.
|
|
Eksperimentel: Algorithm
IV sedation dose calculated by study algorithm
|
IV sedation dosing calculated by algorithm
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Pain with suction curettage
Tidsramme: Measured on Day 1 (day of enrollment), immediately (within one minute) after completion of suction curettage and speculum removal
|
Subjects' pain score with suction curettage on a 0-100 21-point scale
|
Measured on Day 1 (day of enrollment), immediately (within one minute) after completion of suction curettage and speculum removal
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Pain with paracervical block
Tidsramme: Measured on Day 1 (day of enrollment), immediately after paracervical block
|
Pain with paracervical block will be measured (a) on a 21-point 0 to 100 scale (in increments of five), and (b) on a subjective scale of "no pain, mild pain, moderate pain or severe pain."
Pain will be measured immediately after paracervical block.
|
Measured on Day 1 (day of enrollment), immediately after paracervical block
|
|
Pain with cervical dilation
Tidsramme: Measured on Day 1 (day of enrollment), immediately after cervical dilation
|
Pain with cervical dilation will be measured (a) on a 21-point 0 to 100 scale (in increments of five), and (b) on a subjective scale of "no pain, mild pain, moderate pain or severe pain."
Pain with cervical dilation will be measured immediately after cervical dilation.
|
Measured on Day 1 (day of enrollment), immediately after cervical dilation
|
|
Post-operative pain
Tidsramme: Measured on Day 1 (day of enrollment), 15 minutes post-operatively
|
Post-operative pain will be measured (a) on a 21-point 0 to 100 scale (in increments of five), and (b) on a subjective scale of "no pain, mild pain, moderate pain or severe pain."
Pain will be measured 15 minutes post-operatively when the patient is in the recovery room.
|
Measured on Day 1 (day of enrollment), 15 minutes post-operatively
|
|
Patient satisfaction with pain control
Tidsramme: Measured on Day 1 (day of enrollment), 15 minutes post-operatively
|
Patients will be asked about their general satisfaction with pain control, what their pain was compared to what they expected, whether they would chose the same pain management strategy again, and whether they would recommend their strategy of pain management to a friend.
|
Measured on Day 1 (day of enrollment), 15 minutes post-operatively
|
|
Side effects
Tidsramme: Measured on Day 1 (day of enrollment), 15 minutes post-operatively
|
Investigators will assess side effects for all patients, including nausea, vomiting, dizziness, and drowsiness.
|
Measured on Day 1 (day of enrollment), 15 minutes post-operatively
|
Andre resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Doses given over the duration of the study
Tidsramme: Measured on Day 1 (day of enrollment), intraoperatively
|
To assess whether use of the algorithm changes physician's behavior in the standard care arm, investigators will also examine doses given over the duration of the study, to see if a "learning curve" develops among the physicians based on their experience with the algorithm.
|
Measured on Day 1 (day of enrollment), intraoperatively
|
|
Physician assessment of pain control
Tidsramme: Measured on Day 1 (day of enrollment), post-operatively
|
Investigators will also have the physician assess patients' pain control, whether they felt the dose was appropriate and how easy or difficult it was to determine the patients' doses of pain medication.
|
Measured on Day 1 (day of enrollment), post-operatively
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Samarbejdspartnere
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart
1. november 2013
Primær færdiggørelse (Faktiske)
1. juli 2015
Studieafslutning (Faktiske)
1. juli 2015
Datoer for studieregistrering
Først indsendt
1. november 2013
Først indsendt, der opfyldte QC-kriterier
19. november 2013
Først opslået (Skøn)
25. november 2013
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Skøn)
17. august 2015
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
14. august 2015
Sidst verificeret
1. august 2015
Mere information
Begreber relateret til denne undersøgelse
Andre undersøgelses-id-numre
- SFPRF7-6
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Graviditet, uplanlagt
-
King's College Hospital NHS TrustEuropean Association for the Study of the LiverRekrutteringCirrhose, lever | HELLP syndrom | Intrahepatisk kolestase af graviditet | Graviditetssygdom | AFLP - Acute Fatty Lever of PregnancyDet Forenede Kongerige
Kliniske forsøg med Standard care
-
Beijing BiotechRekrutteringEpitelial ovariecancer | Æggelederkarcinom | Primært peritonealt karcinom | Recidiverende eller refraktær sygdom efter standardbehandlingerKina
-
The First Affiliated Hospital of Air Force Medicial...RekrutteringRefraktær membranøs nefropatiKina
-
Xuanwu Hospital, BeijingBioray LaboratoriesIkke rekrutterer endnuMultipel sclerose | Neuromyelitis Optica Spectrum Disorders | Kronisk inflammatorisk demyeliniserende polyradiculoneuropati | Myasthenia Gravis, generaliseretKina
-
The Second Hospital of Shandong UniversityAktiv, ikke rekrutterende
-
The Second Hospital of Shandong UniversityAktiv, ikke rekrutterendeSikkerhed og effektivitet af cellulære lægemidler, objektiv responsrate for forsøgspersoner osvKina
-
Cellular Biomedicine Group Ltd.The First Affiliated Hospital with Nanjing Medical UniversityAfsluttetRefraktært diffust stort B-cellet lymfomKina
-
Baylor College of MedicineThe Methodist Hospital Research Institute; Center for Cell and Gene Therapy...RekrutteringKronisk lymfatisk leukæmi | Non-Hodgkin lymfom | Akut lymfatisk leukæmiForenede Stater
-
Zhejiang UniversityCarbiogene Therapeutics Co. Ltd.RekrutteringKlinisk forsøg med autologe GPC3 CAR-T-celler (CBG166) terapi for avanceret hepatocellulært karcinomAvanceret hepatocellulært karcinomKina
-
Nexcella Inc.Immix Biopharma, Inc.RekrutteringLet kæde (AL) amyloidoseForenede Stater
-
Second Affiliated Hospital, School of Medicine,...RekrutteringRecidiverende og refraktær B-celle lymfomKina